Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

NCT01273909 is registered in ClinicalTrials.gov with The National Institute of Lymphology as lead sponsor.

NCT NCT01273909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01273909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment
Lead sponsor
The National Institute of Lymphology
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2010
Completion date
January 31, 2016
Enrollment
1,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acquired lymphedema, breast cancer, congenital lymphedema, hereditary breast/ovarian cancer (brca1, brca2)